baber/WOPTO huggingface dataset:
Patent CA-2286395-A1 (CA)
Title: Production method of heterologous protein
Inventor: OHYA TOMOSHI
IPC: C12P21/02
Filed: 1998-04-03
Abstract: A production method of a heterologous protein, comprising culturing a heterologous protein-producing host prepared by gene manipulation in a medium containing a fatty acid or a salt thereof, and a surfactant and harvesting the heterologous protein from the culture. The production amount of the heterologous protein produced by a heterologous protein-producing host can be increased. Moreover, since decomposition of the heterologous protein by an enzyme derived from the host can be inhibited, enabling large scale production of a heterologous protein.
Patent CA-2286748-A1 (CA)
Title: Dispositif de coulage continu de deux lignes paralleles
Inventor: SVENSSON ERIK
IPC: B22D11/115
Filed: 1998-03-06
Abstract: L'invention concerne un frein magnétique qui génère au moins un champ magnétique basse fréquence statique ou périodique lors du coulage de lignes parallèles dans une coquille. La coquille présente un moule (10) rectangulaire doté d'une séparation (13) interne qui le subdivise en deux sous-moules (11a, 11b). Le champ magnétique agit avec une direction sensiblement identique sur toute la largeur du moule rectangulaire et a une répartition sensiblement symétrique dans les deux sous-moules. Le frein possède un premier aimant plaqué sur un premier grand côté du moule rectangulaire et un second aimant de polarité opposée plaqué sur le second grand côté opposé. Le matériau magnétique des aimants est réparti de telle façon que les deux aimants ont chacun deux sous-poles magnétiques de même polarité placés adjacents sur chacun des deux grands côtés du moule rectangulaire. Chaque sous-pole est placé de façon symétrique le long du grand côté du sous-moule respectif.
Patent CA-2288069-A1 (CA)
Inventor: OLSON DAVID B
IPC: C08F220/22
Filed: 1997-09-09
Abstract: Described are alkyl-substituted brominated aromatic ester (meth)acrylate monomers having an index of refraction of at least 1.55 of the following formula:   (see formula I) Units of the monomer may be polymerized and the resulting polymer may be used in preparing an optical product.
Patent CA-2295037-A1 (CA)
Inventor: CARICOFE RALPH BOYER
IPC: A61K9/00
Filed: 1998-07-22
Abstract: The invention relates to an aqueous pharmaceutical composition for oral administration comprising ranitidine, or a pharmaceutically acceptable salt thereof, characterised in that the composition contains low colour, metal, turbidity (LCMT) sucrose.
Patent CA-2295484-A1 (CA)
Title: A system and method for determining which of a plurality of visually indistinguishable objects have been marked with a covert indicator
Inventor: FORMOSA JOSEPH S
IPC: G07D7/12
Filed: 1998-07-07
Abstract: A system and method for determining which of a plurality of visually indistinguishable objects (14) have been marked with a covert indicator (10) in which a portion of a surface (12) of each of a first type of objects (14) are provided with a covert holographic indicator (10) which is exposed to be viewed but which is detectable only when illuminated with a coherent reference light of predetermined wavelength. The surfaces (12) of objects (14) are scanned with a coherent reference light with the predetermined wavelength, and evaluated to determine whether the scanned surfaces include the covert holographic indicator (10). The presence of the covert holographic indicator (10) indicates that the object (14) on which the covert holographic indicator (10) is detected is one of the first type of objects. The first type of object may be a winning game ticket, or a genuine, as opposed to counterfeit, article.
Patent CA-2298678-A1 (CA)
Title: Ventilation valve for a mold in producing insulators
Inventor: JEUTHNER HERMANN
IPC: H01B19/00
Filed: 1998-07-29
Abstract: The aim of the invention is to provide an improved ventilation valve, especially for ventilating a mould in the production of umbrella type insulators, so that harmful deformation of the moulded body can be avoided during removal from the mould. This is achieved by providing the ventilation valve with a rod-like or pin-shaped housing with an orifice on one of its front faces and by providing a valve body on the other front face which is detachably mounted in an axial extension of the valve housing.
Patent CA-2303010-A1 (CA)
Title: Integrated system including medication delivery pen, blood monitoring device, and lancer
Inventor: ANTOSHKIW WILLIAM THOMAS
IPC: A61B5/145
Filed: 2000-03-23
Abstract: A portable diagnostic and medication delivery system that includes a housing and a monitor disposed in the housing for monitoring a characteristic of a bodily fluid sample obtained from an individual. A medication delivery pen and a lancer are each removably mounted to the housing. The monitor, which may be integrated into the housing, may monitor blood glucose levels, for example, and the pen may be employed for the delivery of insulin.
Patent CA-2303231-A1 (CA)
Inventor: REED MARY K
IPC: A61B19/08
Filed: 1998-09-29
Abstract: An ophthalmic surgical drape and a method of applying the drape to a patient.  The ophthalmic surgical drape is made from a sheet having an aperture in the interior of the sheet, and at least two tear lines in the sheet extending from the aperture. The drape also has a field of skin compatible adhesive adjacent the aperture, with the field being traversed by the tear lines so as to divide the field into at least two portions. The drape may be provided in a folded condition in which tearing can be accomplished so as to divide the drape into two sections before the drape is unfolded. Also disclosed are two tear lines disposed along an oblique angle, and a method of applying the drape.
Patent CA-2309602-A1 (CA)
Inventor: PACIOTTI GIULIO F
IPC: A61K47/48
Filed: 1998-11-10
Abstract: The methods and compositions of the present invention are directed to enhancing an immune response and increasing vaccine efficacy through the simultaneous or sequential targeting of specific immune system components.  More particularly, specific immune components, such as macrophages, dentritic cells, B cells and T cells, are individually activated by component-specific immunostimulating agents. One such component-specific immunostimulating agent is an antigen-specific, species-specific monoclonal antibody. The invention is also directed to a method for the in vitro production of the antigen-specific, species-specific monoclonal antibodies which relies upon the in vitro conversion of blood-borne immune cells, such as macrophages and lymphocytes.  Vaccine efficacy is enhanced by the administration of compositions containing component-specific immunostimulating agents and other elements, such as antigens or carrier particles, such as colloidal methods, such as gold.
Patent CA-2310489-A1 (CA)
Inventor: BEAUDOIN NORMAND
IPC: F02B75/02
Filed: 2000-05-23
Abstract: The invention concerns a method for making a two-stroke engine, capable of running exclusively on gas, or a back draught-free engine by not using fixed connecting rods but rather standard rods, thereby enabling to keep a small-size engine.
Patent CA-2312060-A1 (CA)
Title: Lotions containing vitamin d3 derivatives
Inventor: SANO KEIKO
IPC: A61K9/08
Filed: 1998-12-08
Abstract: Lotions containing maxacalcitol sustained in a stable state therein and having an excellent percutaneous absorbability. Namely, lotions containing maxacalcitol as the active ingredient and, as additional components, nonionic surfactants optionally together with polyhydric alcohols and solubilizing agents.
Patent CA-2313783-A1 (CA)
Title: Pharmaceutical compositions of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a salt thereof
Inventor: WIGGINS NORMAN ALFRED
IPC: A61K33/30
Filed: 2000-08-04
Abstract: "The invention concerns a pharmaceutical composition comprising the HMG CoA reductase inhibitor (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin 5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof as the active ingredient, which remains stable over a prolonged period."
Patent CA-2316442-A1 (CA)
Title: Digital watermarking technique
Inventor: TANAKA NOBUYUKI
IPC: H04N21/8358
Filed: 2000-08-18
Abstract: A watermarking system allowing both sufficiently high quality of watermarked moving pictures and enhanced ease of watermark detection is disclosed. A watermark level of a watermark to be embedded into a picture of data is changed depending on the picture type of a selected block of frequency component data, and then a watermark having the watermark level is inserted into the selected block of frequency component data.      Therefore, a moving-picture can be effectively embedded with a digital watermark without substantially reducing the quality of image and the digital watermark can be detected reliably.      A relative proportion of watermark levels of I-picture, B-picture, and P-picture is preferably set to 10:7:5.
Patent CA-2317843-A1 (CA)
Inventor: STAMBACK MARK A
IPC: F01L3/08
Filed: 2000-09-08
Abstract: A valve stem seal assembly includes a resilient seal member mounted to a shell body having a downwardly extending skirt. At least one alignment pad or tang is provided in the skirt of the shell body for improved gripping of an outside diameter of a valve guide. In one embodiment, the alignment pad includes an inwardly projecting ramp portion connected to a generally longitudinally extending land portion and terminates in an inwardly projecting tang adjacent the land portion. In another embodiment, a valve stem seal assembly includes at least one tang having a generally arcuate end portion with a pair of spaced apart upwardly extending shoulders for gripping a valve guide.
Patent CA-2319607-A1 (CA)
Title: A roto-dynamic high pressure machine
Inventor: ARBEUS ULF
IPC: F04D29/22
Filed: 2000-09-14
Abstract: An improved pump or compressor of the centrifugal type is provided, which has an impeller surrounded by a housing and having a disk, a first plurality of vanes provided near the disk, cover disks provided about the edges of the vanes, and a second plurality of vanes provided on the outwardly directed sides of the cover disks. Two pressure steps are created by the first plurality of vanes, each side of the disk and the cover disks. Two additional pressure steps are created by the second plurality of vanes, the cover disks, and pump housing walls that are located adjacently to the second plurality of vanes. Single or multiple flow conduits are arranged among the various inlets and outlets of the pressure steps, such that a fluid flows through the various pressure steps, with the last pressure step being closest to a motor unit and an outlet connected to the last pressure step being on the same side and facing in the same direction as an inlet. Demands for higher efficiencies, improved compactness and a simpler, more symmetrical design are met by this configuration.
Patent CA-2325585-A1 (CA)
Inventor: LIFE PAUL FREDERICK
IPC: C07K14/715
Filed: 1999-03-25
Abstract: La présente invention concerne l'utilisation d'un antagoniste d'OSM, tel qu'un anticorps ou une petite molécule, dans l'élaboration d'un médicament destiné au traitement ou à la prophylaxie d'une arthropathie inflammatoire ou d'un trouble inflammatoire, et l'utilisation d'OSM dans le criblage de ce type d'antagonistes.
Patent CA-2328298-A1 (CA)
Title: Method for electroelution of a biological sample and implementing device
Inventor: SANTORO LYSE
IPC: C12Q1/6806
Filed: 1999-04-09
Abstract: The invention concerns a method for treating by the action of an electric field in liquid medium a biological sample comprising both a nucleic material and a non-nucleic material, which consists in: a) providing a buffer solution; b) providing a permeable membrane, in contact on one side with the buffer solution, and having a predetermined interrupting threshold to stop the nucleic material, on said buffer solution side, when it is migrating under the action of the electric field; c) generating said electric field; d) placing the biological sample in the buffer solution, upstream of the membrane, along the nucleic material circulating direction by the electric field action. The invention is characterised in that it consists in: directly applying the electric field to the biological sample in the buffer solution, for a limited time interval determined by sufficient time for the nucleic material to arrive on the membrane and by its presence on the buffer solution side, and by the fact that at said time interval end the non-nucleic material has not migrated and/or is still in the process of migrating towards said membrane; removing the nucleic material after said time interval, and thereby electroeluting from the biological sample at least the nucleic material. The invention also concerns the implementing device.
Patent CA-2328446-A1 (CA)
Inventor: HARTMAN ROBERT L
IPC: B23B31/107
Filed: 1999-11-12
Abstract: A pneumatic impact power tool (10) has a tool body (12) with a bit-receiving  axial bore (19). A cap (30) is threaded on the tool body (12) and has an end  wall (32) spaced from an end surface (21) to define a cavity (38) and a lobe d opening (33) matably receiving a like-lobed bit shank (51). Spring-biased balls (42) project into the cavity (38) from radial bores (37) in the end ca p (30) to engage the shank lobes (55) and bias them to a rotational position n on- aligned with the opening lobes (34) to inhibit removal. The cavity (38) is dimensioned to afford a slight axial clearance to accommodate axial movement  of the lobes (55). A cover (45) on the end cap (30) is recessed to receive t he bias springs (41), retaining both the springs (41) and the cover (45) in place. The end cap (30) has a annular channel (35) communicating with an exhaust passage (22) in the tool body (12) and four exhaust ports (36) in th e end wall (32).
Patent CA-2329143-A1 (CA)
Inventor: COHEN LAWRENCE K
IPC: C07K14/755
Filed: 1999-05-27
Abstract: L'invention concerne des procédés et des matériaux permettant l'expression de polypeptides comprenant une activité facteur VIII. Ces procédés comprennent l'administration d'au moins deux vecteur rAAV codant pour différents domaines du facteur VIII humain et au moins pour les chaînes lourde et légère.
Patent CA-2336509-A1 (CA)
Title: Triggered non-linear animation
Inventor: LANCIAULT ROBERT
IPC: G06T13/40
Filed: 2001-02-15
Abstract: A method and apparatus are provided for generating animation data, comprising the steps of displaying a character (502) that can be animated; triggering (605) the reading of input animation sequences (305) in response to manual operation of manually controllable input means (108,109,110); animating (606) said character (502) in response to said input animation sequences (305); and storing (608) said triggered animation sequence (907) in storage means as an output animation sequence (401).
Patent CA-2338328-A1 (CA)
Inventor: WANG JIALUN
IPC: A61K31/428
Filed: 1999-07-20
Abstract: Small molecule inhibitors of Bcl-2 function are used to induce apoptosis of cells which are subject to Bcl-2, which cells are otherwise subject to Bcl-2 mediated blockage of apoptosis. The compounds are useful for treating cancer, autoimmune disorders and viral infection.
Patent CA-2338372-A1 (CA)
Title: Water-in-oil microemulsion for providing cosmetic attributes to fabric softening base composition
Inventor: TUMMERS DOMINIQUE
IPC: C11D3/20
Filed: 1999-07-29
Abstract: A perfume-containing water-in-oil microemulsion is provided which is capable of being mixed with an aqueous fabric softener base composition to provide perfume thereto. The use of the defined microemulsion enables the addition of perfume as well as other cosmetic attributes to an aqueous base composition under conditions of low shear while avoiding any problems of gelation or physical instability in the finished fabric softener product.
Patent CA-2338422-A1 (CA)
Inventor: SCHWARTZ FREDERICK A
IPC: B23K26/06
Filed: 1999-07-09
Abstract: This invention relates to an improved laser beam useful in material surface processing and an apparatus for producing the improved laser beam. The improved laser beam of the present invention comprises a power distribution that is more intense at the outer regions than in the central region. The invention includes an apparatus comprising a power spherical and cylindrical optical elements aligned to focus and/or shape a laser beam into a novel profile useful in material surface processing. The invention further includes a method of using this apparatus to focus and/or shape a laser beam for producing Laser Induced Surface Improvements, hereinafter referred to as "LISI".
Patent CA-2338695-A1 (CA)
Inventor: HIROTA TERUTO
IPC: G06F3/16
Filed: 2000-05-24
Abstract: A semiconductor memory card stores a plurality of audio objects (AOBs) that compose a plurality of tracks and playlist information showing a reproduction order for the tracks. The semiconductor memory card also stores, as resume information (PLMG_RSM_PL), (1) a Playlist_Number showing which playlist information was used the last time playback was performed for the semiconductor memory card, (2) a Track_Number showing the last track to be played back, and (3) a Playback_Time showing a position where playback was stopped as a time expressed in relation to the start of the track.
Patent CA-2340920-A1 (CA)
Title: A method for preventing the onset of asthma
Inventor: DE CLERCQ JOHAN
IPC: A61P11/06
Filed: 1999-08-14
Abstract: The present invention relates to a method for preventing the onset of asthma which comprises administering to a patient a therapeutically effective amount of cetirizine, an individual optical isomer thereof or a pharmaceutically acceptable salt thereof.
Patent CA-2341630-A1 (CA)
Title: Data providing system and method
Inventor: ITO NORIKO
IPC: G06F17/30
Filed: 2001-03-20
Abstract: Position data and spot data of explanation contents are stored in a spot data database in a center. Preference data of the individual users are stored in a preference data database. Group's preference data of user groups are stored in group's preference data database in the center. When the center extracts each user's present time and present position from data received from the user, it selects spot data on the basis of the user's present time and present position and also preference data and user group's preference data obtained with user ID from the preference data database and the user group's preference data database, and instructs transmission of the selected spot data to the pertinent user's portable data terminal. Thus, it is possible to provide apt data to users even when the users take action patterns different from a usual action pattern.
Patent CA-2342390-A1 (CA)
Inventor: BAKER FIONA
IPC: A61K31/495
Filed: 1999-09-09
Abstract: A sustained release ranolazine formulation contains an intimate mixture of ranolazine and a partially neutralized pH-dependent binder to form a film that is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5. The formulation is suitable for twice daily administration of ranolazine and is useful for controlling the rate of dissolution of ranolazine, and to maintain human plasma ranolazine levels at between 550 and 7500 ng base/mL.
Patent CA-2345607-A1 (CA)
Inventor: THIBAULT THOMAS M
IPC: G07C5/08
Filed: 2000-07-27
Abstract: A system and method for automatically calculating safety-related compliance data for vehicle operators. Vehicle operators enter an identification code and status information into a mobile communication terminal (106) located on a vehicle (102). The identification code and status information is generally stored in a memory located within the mobile communication device. The identification code and status information can be transmitted (108) to a central station (104) where it can be processed to determine compliance with safety regulations. The resulting data may be transmitted (108) back to the vehicle (102) upon request. In another embodiment, a processor located within the mobile communication terminal (106) processes the identification code and status information. The resultant data may then be transmitted (108) to the central station (104) or presented to the vehicle operator upon request.
Patent CA-2347463-A1 (CA)
Title: Anesthesia cart
Inventor: RICHTER-DYCAICO PAULA A
IPC: A61J3/00
Filed: 1999-10-14
Abstract: A computerized medication dispensing station (100) that addresses anesthesia medication management and tracking problems is disclosed. Medications, including narcotic and non-narcotic, and supplies for use in anesthesia, are stored in secured, semi-secured, and unsecured containers (114, 116) of a mobile station (100). A computer housed (122) in the station (100) is used to track the anesthesiology items that have been removed from the station (100). For each item removed, the time of removal, who removed it, and to whom it was administered is tracked. Items that are not administered to a patient are returned to the pharmacy or wasted (i.e., disposed in accordance with regulations). Each type of event (administration to a patient, return, or waste) is documented so that a health care institution can track usage of items, including narcotic medications, for use in anesthesia.
Patent CA-2347917-A1 (CA)
Inventor: DOOLEY MICHAEL JOHN
IPC: G16B50/30
Filed: 1999-10-21
Abstract: A method of protein engineering is provided wherein a searchable computer database is created comprising entries in the form of descriptions of a location and orientation in 3D space of side chains of the constituent amino  acid residues of a framework protein. A query is created which corresponds t o a description of a location and orientation in 3D space of respective side chains of amino acid residues of a sample protein. The location and orientation in 3D space of constituent side-chains is preferably described a s a C.alpha.-C.beta. vector. The query is used to search the database and thereby identify a hit which corresponds to a framework protein having structural similarity with said sample protein. Framework protein "hits" so identified may be suitable candidates for further modification. A particular  advantage of the present invention is that a modified framework protein may display one or more desired characteristics, such as a function similar to o r inhibitory of the sample protein.
Patent CA-2348295-A1 (CA)
Title: Novel thermostable collagen-decomposing enzyme, novel microorganism producing the enzyme and process for producing the enzyme
Inventor: AKAI MINORU
IPC: C12N1/20
Filed: 1999-11-16
Abstract: Bacillus sp. NTAP-1 having been deposited under accession number FERM BP-6926; and a collagen-decomposing enzyme produced by bacterium.  The above enzyme (1) has a capability of hydrolyzing, at the highest efficiency, collagen and gelatin from among casein, gelatin, albumin and collagen; (2) shows the optimum pH of 3.5 to 4.5; (3) shows the optimum temperature of 65 to 70°C; (4) after heating at 60°C at pH 6.0 for 4 hours, sustains an activity amounting to 60% or more of the level before the heat treatment; (5) remains stable at pH 3 to 6; and a molecular weight of approximately 46,000 when measured by SDS-PAGE.
Patent CA-2348914-A1 (CA)
Inventor: BUSCHECK GREGORY D
IPC: H04N5/445
Filed: 1999-10-28
Abstract: A method for managing entertainment system data (231) includes obtaining a record (232) corresponding to a first entertainment selection that is selected. A selectable identifier (222) corresponding to a first set of entertainment system data (231) in the record is presented on a display device (222). A search for a second entertainment selection having a corresponding second set of entertainment system data (231) related to the first set of entertainment system data (231) is performed when the selectable identifier (222) is selected. A result of the search is presented on the display device (222).